News and Press Releases

CryoLogyx Completes £500k Seed Funding Round

Funding round led by private UK business angels and the Wider Oxford Technology Angel Network Investment to support commercialisation of pre-plated, assay-ready, cryopreserved cells for drug discovery, diagnostic and cell...

Category: Biotechnology
Posted: March 18, 2024

The Venture Centre, Sir William Lyons Road, Coventry, CV4 7EZ.

HepaRegeniX publishes data for its first-in-class MKK4 inhibitor HRX-215 for the treatment of acute and chronic liver diseases in Cell

Clinical and pre-clinical data generated from collaborations between the Tuebingen University Hospital, Germany, researchers from the Mayo Clinic in Rochester, USA and HepaRegeniX HRX-215 proved to be safe and well...

Category: Biotechnology
Posted: March 15, 2024

Single Use Support Opens US Office

Fluid and cold chain management expert Single Use Support has opened a subsidiary in Lexington, Massachusetts, US. Equipped with a product showroom, the office will also serve as a base...

Category: Logistics
Posted: March 15, 2024

Endach 36 6330 Kufstein Austria

Viroclinics-DDL Changes Name to Cerba Research

14 March 2024 -- Rotterdam, the Netherlands -- Viroclinics-DDL (referred to herein as Cerba Research, the Netherlands), a world leading vaccine and antiviral specialty laboratory providing research and clinical trial...

Category: Biotechnology, Clinical Trials
Posted: March 15, 2024

Klaartestraat 20, 9052 Ghent, Belgium

Darling Ingredients’ health brand Rousselot announces online access to research- and technical-grade X-Pure Gelatins through BIO INX

13 March 2024 – Darling Ingredients’ health brand Rousselot, a global leader in gelatin- and collagen-based solutions, announced today that its high-quality, research- and technical-grade gelatins are now available for...

Category: Biotechnology, Drug Discovery
Posted: March 14, 2024

Rousselot BV, Kanaaldijk Noord 20 5691 NM SON

Northway Biotech’s CEO, Prof V A Bumelis, inaugurated as Honorary Doctor of Klaipėda University, Lithuania

9 February 2024 At the solemn meeting of the Klaipėda University (KU) Senate, the regalia of Honorary Doctor was bestowed upon academician and CEO and Chairman of the Board of...

Category: Biotechnology, Drug Discovery
Posted: March 14, 2024

Anocca AB licenses gene editing technology from EmendoBio Inc

Enabling Technology Supports the Development of Anocca’s Deep Pipeline of TCR-T therapeutics 14 March 2024 – New York, US and Södertälje, Sweden – Anocca AB (Anocca), a leading T-cell receptor-engineered...

Category: Biotechnology, Drug Discovery
Posted: March 14, 2024

Forskargatan 20C 151 36 Södertälje, Sweden

Nuclera appoints Joseph Bertelsen as Chief Commercial Officer

Key appointment to lead global commercial launch of eProtein Discovery platform 14 March 2024 – Cambridge, UK – Nuclera, the biotechnology company enabling rapid protein expression and purification screening through...

Category: Biotechnology, Drug Discovery
Posted: March 14, 2024

One Vision Park, Station Road, Impington, Cambridge, CB24 9NP

ProBioGen Partners with MAPP BIOPHARMACEUTICAL, INC for Ground-breaking Development of Afucosylated Antibody Against Marburg Virus Disease Using GlymaxX Technology

13 March 2024 -- Berlin, Germany -- ProBioGen, a leading CDMO of innovative solutions and services for biopharmaceutical development, is pleased to announce the execution of services and license agreements...

Category: Biotechnology
Posted: March 13, 2024

Herbert-Bayer-Straße 8 13086 Berlin

Faller Packaging announces long-term appointment of new chief executive officer

Dr Michael Faller and Dr Daniel Keesman will step down for reasons of age in the second half of 2024. Dagmar Schmidt will become the new CEO 13 March 2024...

Category: Manufacturing and Packing
Posted: March 13, 2024

Freiburger Strasse 25 D-79183 Waldkirch

Developed by VHIO, a novel AI-based and non-invasive diagnostic tool enables accurate brain tumour diagnosis, outperforming current classification methods

Developed by VHIO’s Radiomics Group in close collaboration with researchers of the Neuro-Radiology Unit at the Bellvitge University Hospital (HUB), DISCERN is a deep learning tool that leverages information of...

Category: Biotechnology, Drug Discovery
Posted: March 13, 2024

C/ Natzaret, 115-117 08035 – BARCELONA – Spain

TMC Pharma champions holistic approach to medical services in rare disease drug development

13 March 2024 – In a recent webinar, rare disease specialist and global clinical research organisation (CRO) TMC Pharma gathered esteemed speakers to share insights into the scope of medical...

Category: Drug Discovery, Pharmaceutical
Posted: March 13, 2024

Lodge Farm Barn Elvetham Park Estate, Fleet Road, Hartley Wintney, Hampshire RG27 8AS, UK

ProteoNic Announces Partnership with Ginkgo Bioworks and Joins the Ginkgo Technology Network

13 March 2024 -- Leiden, the Netherlands -- ProteoNic Biosciences, a leading provider of premium vector technology and services for the production of biologics, today announced a partnership with Ginkgo Bioworks, which...

Category: Biotechnology
Posted: March 13, 2024

J.H. Oortweg 19-21 – 2333 CH Leiden – The Netherlands

ReciBioPharm and GeneVentiv Therapeutics partner to advance first AAV-based gene therapy for haemophilia patients with inhibitors

13 March 2024 -- Stockholm, Sweden -- ReciBioPharm, the advanced and emerging therapies business unit of Recipharm, has announced a collaboration agreement with GeneVentiv Therapeutics, a pre-clinical gene therapy company,...

Category: Biotechnology
Posted: March 13, 2024

Ricoh and ERS Genomics enter into CRISPR/Cas9 license agreement

CRISPR/Cas9 genome editing technology contributes to the expansion of the creation of novel disease model 13 March 2024 -- Tokyo, Japan, and Dublin, Ireland -- Ricoh Company today announced a...

Category: Biotechnology
Posted: March 13, 2024

8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland